Research programme: drug discovery - Anadys/RocheAlternative Names: Drug discovery research programme - Roche
Latest Information Update: 21 Feb 2017
At a glance
- Originator Anadys Pharmaceuticals; Roche
- Developer Roche
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Aug 2002 Preclinical trials in Cancer in USA (unspecified route)